Musculoskeletal steroid injections during the COVID-19 pandemic

INTRODUCTION: This study aims to determine whether musculoskeletal corticosteroid injections increase the risk for COVID-19. METHOD: 734 patients who received a corticosteroid injection during the COVID-19 pandemic were followed and their COVID status within 30 days after the injection checked. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Bugeja, Mark, Mariani, Jasmine, Dowling, Jessica, Stringaro, Giulia, Portelli, Jean Luc, Sant, Kurstein, Casaletto, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294711/
https://www.ncbi.nlm.nih.gov/pubmed/34312576
http://dx.doi.org/10.1016/j.jor.2021.07.017
Descripción
Sumario:INTRODUCTION: This study aims to determine whether musculoskeletal corticosteroid injections increase the risk for COVID-19. METHOD: 734 patients who received a corticosteroid injection during the COVID-19 pandemic were followed and their COVID status within 30 days after the injection checked. The results were then compared with an age and sex matched control group. RESULTS: No statistically significant difference in the frequency of COVID-19 cases between the two groups was found. CONCLUSION: It appears that the use of musculoskeletal corticosteroid injections during the COVID-19 pandemic does not confer increased risk of contracting the virus.

Ejemplares similares